Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REaCT-dexamethasone: Dexamethasone Schedules for Missed Premedication
NCT02815319Phase 4Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jan 2017
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in cancer comparing Standard of care with 8mg PO dexamethasone (2 arms). Primary endpoint: Time to commence docetaxel chemotherapy at 1 year. Started Jan 2017; status: completed.
02
Drugs
dexamethasone
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02815319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02815319.